Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 179

1.

Inhibiting STAT5 by the BET bromodomain inhibitor JQ1 disrupts human dendritic cell maturation.

Toniolo PA, Liu S, Yeh JE, Moraes-Vieira PM, Walker SR, Vafaizadeh V, Barbuto JA, Frank DA.

J Immunol. 2015 Apr 1;194(7):3180-90. doi: 10.4049/jimmunol.1401635. Epub 2015 Feb 27.

PMID:
25725100
2.

Dendritic Cell-Derived Exosomes may be a Tool for Cancer Immunotherapy by Converting Tumor Cells into Immunogenic Targets.

Romagnoli GG, Zelante BB, Toniolo PA, Migliori IK, Barbuto JA.

Front Immunol. 2015 Jan 19;5:692. doi: 10.3389/fimmu.2014.00692. eCollection 2014. Review.

3.

Early pregnancy sex steroids and maternal breast cancer: a nested case-control study.

Fortner RT, Schock H, Kaaks R, Lehtinen M, Pukkala E, Lakso HÅ, Tanner M, Kallio R, Joensuu H, Grankvist K, Zeleniuch-Jacquotte A, Toniolo P, Lundin E, Surcel HM.

Cancer Res. 2014 Dec 1;74(23):6958-67. doi: 10.1158/0008-5472.CAN-14-2150. Epub 2014 Oct 3.

PMID:
25281720
4.

Early pregnancy sex steroids and maternal risk of epithelial ovarian cancer.

Schock H, Surcel HM, Zeleniuch-Jacquotte A, Grankvist K, Lakso HÅ, Fortner RT, Kaaks R, Pukkala E, Lehtinen M, Toniolo P, Lundin E.

Endocr Relat Cancer. 2014;21(6):831-44. doi: 10.1530/ERC-14-0282.

5.

Circulating estrogen metabolites and risk of breast cancer in postmenopausal women.

Arslan AA, Koenig KL, Lenner P, Afanasyeva Y, Shore RE, Chen Y, Lundin E, Toniolo P, Hallmans G, Zeleniuch-Jacquotte A.

Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1290-7. doi: 10.1158/1055-9965.EPI-14-0009. Epub 2014 Apr 27.

6.

Free β-human chorionic gonadotropin, total human chorionic gonadotropin and maternal risk of breast cancer.

Toriola AT, Tolockiene E, Schock H, Surcel HM, Zeleniuch-Jacquotte A, Wadell G, Toniolo P, Lundin E, Grankvist K, Lukanova A.

Future Oncol. 2014 Feb;10(3):377-84. doi: 10.2217/fon.13.208.

7.

JAK2-STAT5 signaling: A novel mechanism of resistance to targeted PI3K/mTOR inhibition.

Yeh JE, Toniolo PA, Frank DA.

JAKSTAT. 2013 Oct 1;2(4):e24635. doi: 10.4161/jkst.24635. Epub 2013 Apr 15.

8.

Targeting STAT5 in hematologic malignancies through inhibition of the bromodomain and extra-terminal (BET) bromodomain protein BRD2.

Liu S, Walker SR, Nelson EA, Cerulli R, Xiang M, Toniolo PA, Qi J, Stone RM, Wadleigh M, Bradner JE, Frank DA.

Mol Cancer Ther. 2014 May;13(5):1194-205. doi: 10.1158/1535-7163.MCT-13-0341. Epub 2014 Jan 16.

9.

Targeting transcription factors: promising new strategies for cancer therapy.

Yeh JE, Toniolo PA, Frank DA.

Curr Opin Oncol. 2013 Nov;25(6):652-8. doi: 10.1097/01.cco.0000432528.88101.1a. Review.

PMID:
24048019
10.

Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study.

Scarmo S, Afanasyeva Y, Lenner P, Koenig KL, Horst RL, Clendenen TV, Arslan AA, Chen Y, Hallmans G, Lundin E, Rinaldi S, Toniolo P, Shore RE, Zeleniuch-Jacquotte A.

Breast Cancer Res. 2013 Feb 26;15(1):R15. doi: 10.1186/bcr3390.

11.

Circulating carotenoids and risk of breast cancer: pooled analysis of eight prospective studies.

Eliassen AH, Hendrickson SJ, Brinton LA, Buring JE, Campos H, Dai Q, Dorgan JF, Franke AA, Gao YT, Goodman MT, Hallmans G, Helzlsouer KJ, Hoffman-Bolton J, Hultén K, Sesso HD, Sowell AL, Tamimi RM, Toniolo P, Wilkens LR, Winkvist A, Zeleniuch-Jacquotte A, Zheng W, Hankinson SE.

J Natl Cancer Inst. 2012 Dec 19;104(24):1905-16. doi: 10.1093/jnci/djs461. Epub 2012 Dec 6.

12.

Defining the genomic signature of the parous breast.

Peri S, de Cicco RL, Santucci-Pereira J, Slifker M, Ross EA, Russo IH, Russo PA, Arslan AA, Belitskaya-Lévy I, Zeleniuch-Jacquotte A, Bordas P, Lenner P, Åhman J, Afanasyeva Y, Johansson R, Sheriff F, Hallmans G, Toniolo P, Russo J.

BMC Med Genomics. 2012 Oct 11;5:46. doi: 10.1186/1755-8794-5-46.

13.

Methylation signature of lymph node metastases in breast cancer patients.

Barekati Z, Radpour R, Lu Q, Bitzer J, Zheng H, Toniolo P, Lenner P, Zhong XY.

BMC Cancer. 2012 Jun 13;12:244. doi: 10.1186/1471-2407-12-244.

14.

Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancer.

Lundin E, Wirgin I, Lukanova A, Afanasyeva Y, Krogh V, Axelsson T, Hemminki K, Clendenen TV, Arslan AA, Ohlson N, Sieri S, Roy N, Koenig KL, Idahl A, Berrino F, Toniolo P, Hallmans G, Försti A, Muti P, Lenner P, Shore RE, Zeleniuch-Jacquotte A.

Cancer Epidemiol. 2012 Oct;36(5):445-52. doi: 10.1016/j.canep.2012.04.006. Epub 2012 May 25.

15.

Premenopausal serum androgens and breast cancer risk: a nested case-control study.

Zeleniuch-Jacquotte A, Afanasyeva Y, Kaaks R, Rinaldi S, Scarmo S, Liu M, Arslan AA, Toniolo P, Shore RE, Koenig KL.

Breast Cancer Res. 2012 Feb 16;14(1):R32.

16.

Mutations of mitochondrial DNA as potential biomarkers in breast cancer.

Cai FF, Kohler C, Zhang B, Chen WJ, Barekati Z, Garritsen HS, Lenner P, Toniolo P, Zhang JJ, Zhong XY.

Anticancer Res. 2011 Dec;31(12):4267-71.

PMID:
22199290
17.

Pregnancy-induced chromatin remodeling in the breast of postmenopausal women.

Russo J, Santucci-Pereira J, de Cicco RL, Sheriff F, Russo PA, Peri S, Slifker M, Ross E, Mello ML, Vidal BC, Belitskaya-Lévy I, Arslan A, Zeleniuch-Jacquotte A, Bordas P, Lenner P, Ahman J, Afanasyeva Y, Hallmans G, Toniolo P, Russo IH.

Int J Cancer. 2012 Sep 1;131(5):1059-70. doi: 10.1002/ijc.27323. Epub 2012 Jan 3.

18.

Determinants of maternal sex steroids during the first half of pregnancy.

Toriola AT, Vääräsmäki M, Lehtinen M, Zeleniuch-Jacquotte A, Lundin E, Rodgers KG, Lakso HA, Chen T, Schock H, Hallmans G, Pukkala E, Toniolo P, Grankvist K, Surcel HM, Lukanova A.

Obstet Gynecol. 2011 Nov;118(5):1029-36. doi: 10.1097/AOG.0b013e3182342b7f. Erratum in: Obstet Gynecol. 2012 Jan;119(1):186-7.

19.

Postmenopausal circulating levels of 2- and 16α-hydroxyestrone and risk of endometrial cancer.

Zeleniuch-Jacquotte A, Shore RE, Afanasyeva Y, Lukanova A, Sieri S, Koenig KL, Idahl A, Krogh V, Liu M, Ohlson N, Muti P, Arslan AA, Lenner P, Berrino F, Hallmans G, Toniolo P, Lundin E.

Br J Cancer. 2011 Oct 25;105(9):1458-64. doi: 10.1038/bjc.2011.381. Epub 2011 Sep 27.

20.

Insulin-like growth factor-I and C-reactive protein during pregnancy and maternal risk of non-epithelial ovarian cancer: a nested case-control study.

Toriola AT, Surcel HM, Lundin E, Schock H, Grankvist K, Pukkala E, Chen T, Toniolo P, Lehtinen M, Zeleniuch-Jacquotte A, Lukanova A.

Cancer Causes Control. 2011 Nov;22(11):1607-11. doi: 10.1007/s10552-011-9828-2. Epub 2011 Aug 11.

PMID:
21833488
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk